Log In
Print this Print this

Insumera (PE0139)

  Manage Alerts
Collapse Summary General Information
Company PhaseBio Pharmaceuticals Inc.
DescriptionHuman monomeric long-acting basal insulin fused to an elastin-like polypeptide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today